Borderline hypercholesterolaemia: when to introduce drugs.
نویسندگان
چکیده
منابع مشابه
Borderline hypercholesterolaemia: when to introduce drugs.
'Please do not write any more articles about cholesterol and coronary disease and the diet and drugs which are supposed to influence them. The facts about coronary disease are these: the less atheromatous your ancestors, the harder your water, and the more habitual exercise you take, the less likely you are to be troubled by it. Do stop bothering about whether your fats are saturated or unsatur...
متن کاملDrugs in the Classroom: Using Pharmacokinetics to Introduce Biomathematical Modeling
Pharmacokinetics is an excellent way to introduce biomathematical modeling at the sophomore level. Students have the opportunity to develop a mathematical model of a biological phenomenon to which they all can relate. Exploring pharmacokinetics takes students through the necessary stages of mathematical modeling: determining the goals of the model, deciphering between the biological aspects to ...
متن کاملIndia should introduce a new Drugs Act.
www.thelancet.com Vol 383 January 18, 2014 203 This report results from research funded by the European Union Seventh Framework Programme Theme: Health-2009-4.3.2-2 (Grant no. 242262) under the title Access to Medicines in Africa and South Asia (AMASA). The project team includes partners at the Swiss Tropical and Public Health Institute at the University of Basel (Switzerland), University of Ed...
متن کاملHypercholesterolaemia: optimal treatment by next-generation drugs?
ticular, homozygous autosomal dominant hypercholesterolaemia, an orphan disease caused by mutations in the LDL receptor, apolipoprotein B (APOB), or PCSK9, is characterised by elevated LDL-C levels [8]. At the same time as the approval of evolocumab, the US Food and Drug Administration (FDA) approved another PCSK9 inhibitor, alirocumab (Praluent) produced by Sanofi and Regeneron. Alirocumab was...
متن کاملScales to climb borderline personalities: when science goes nowhere.
Although these psychosocial scales are increasingly used, scepticism and confusion remain regarding the ability of many scales to summarise composite indices and if they are meaningful in orienting a conclusive clinical decision. We explore some of the limitations regarding scales use and misuse in science. The purpose of the review by Binks et al. [1] is to evaluate the evidence for the effica...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Postgraduate Medical Journal
سال: 1989
ISSN: 0032-5473
DOI: 10.1136/pgmj.65.766.543